NCT00340691View on ClinicalTrials.gov

Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis

PHASE2CompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

December 6, 2004

Primary Completion Date

October 4, 2007

Conditions
Mansonella Perstans InfectionMp Microfilaremia
Interventions
DRUG

Doxycycline

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), 9000 Rockville Pi, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00340691 - Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis | Biotech Hunter | Biotech Hunter